495 related articles for article (PubMed ID: 7889287)
1. A pharmacological profile of the novel, peripherally-selective kappa-opioid receptor agonist, EMD 61753.
Barber A; Bartoszyk GD; Bender HM; Gottschlich R; Greiner HE; Harting J; Mauler F; Minck KO; Murray RD; Simon M
Br J Pharmacol; 1994 Dec; 113(4):1317-27. PubMed ID: 7889287
[TBL] [Abstract][Full Text] [Related]
2. Central and peripheral actions of the novel kappa-opioid receptor agonist, EMD 60400.
Barber A; Bartoszyk GD; Greiner HE; Mauler F; Murray RD; Seyfried CA; Simon M; Gottschlich R; Harting J; Lues I
Br J Pharmacol; 1994 Mar; 111(3):843-51. PubMed ID: 8019761
[TBL] [Abstract][Full Text] [Related]
3. GR94839, a kappa-opioid agonist with limited access to the central nervous system, has antinociceptive activity.
Rogers H; Birch PJ; Harrison SM; Palmer E; Manchee GR; Judd DB; Naylor A; Scopes DI; Hayes AG
Br J Pharmacol; 1992 Aug; 106(4):783-9. PubMed ID: 1327387
[TBL] [Abstract][Full Text] [Related]
4. Novel D-amino acid tetrapeptides produce potent antinociception by selectively acting at peripheral kappa-opioid receptors.
Vanderah TW; Largent-Milnes T; Lai J; Porreca F; Houghten RA; Menzaghi F; Wisniewski K; Stalewski J; Sueiras-Diaz J; Galyean R; Schteingart C; Junien JL; Trojnar J; Rivière PJ
Eur J Pharmacol; 2008 Mar; 583(1):62-72. PubMed ID: 18282565
[TBL] [Abstract][Full Text] [Related]
5. Peripheral effects of the kappa-opioid agonist EMD 61753 on pain and inflammation in rats and humans.
Machelska H; Pflüger M; Weber W; Piranvisseh-Völk M; Daubert JD; Dehaven R; Stein C
J Pharmacol Exp Ther; 1999 Jul; 290(1):354-61. PubMed ID: 10381799
[TBL] [Abstract][Full Text] [Related]
6. The peripherally acting kappa-opiate agonist EMD 61753 and analogues: opioid activity versus peripheral selectivity.
Gottschlich R; Barber A; Bartoszyk GD; Seyfried CA
Drugs Exp Clin Res; 1995; 21(5):171-4. PubMed ID: 8846746
[TBL] [Abstract][Full Text] [Related]
7. Mu- and kappa-opioid receptor agonists produce peripheral inhibition of neurogenic plasma extravasation in rat skin.
Barber A
Eur J Pharmacol; 1993 May; 236(1):113-20. PubMed ID: 8391450
[TBL] [Abstract][Full Text] [Related]
8. DPI-3290 [(+)-3-((alpha-R)-alpha-((2S,5R)-4-allyl-2,5-dimethyl-1-piperazinyl)-3-hydroxybenzyl)-N-(3-fluorophenyl)-N-methylbenzamide]. I. A mixed opioid agonist with potent antinociceptive activity.
Gengo PJ; Pettit HO; O'Neill SJ; Wei K; McNutt R; Bishop MJ; Chang KJ
J Pharmacol Exp Ther; 2003 Dec; 307(3):1221-6. PubMed ID: 14534368
[TBL] [Abstract][Full Text] [Related]
9. CI-977, a novel and selective agonist for the kappa-opioid receptor.
Hunter JC; Leighton GE; Meecham KG; Boyle SJ; Horwell DC; Rees DC; Hughes J
Br J Pharmacol; 1990 Sep; 101(1):183-9. PubMed ID: 2178014
[TBL] [Abstract][Full Text] [Related]
10. Effects of GR-89696 and the novel peripherally selective OP2 agonists, EMD-61569 and EMD-61747, against focal cerebral ischemia in the rat.
Barber A; Bender HM; Gottschlich R; Greiner HE; Harting J; Mauler F; Seyfried CA
Methods Find Exp Clin Pharmacol; 1999 Mar; 21(2):105-13. PubMed ID: 10327391
[TBL] [Abstract][Full Text] [Related]
11. Some pharmacological properties of a newly synthesized 3-acetoxy-6 beta-acetylthio-10-oxo-N-cyclopropylmethyl-dihydronormorphine (KT-95).
Hosoki R; Niizawa S; Koike K; Sagara T; Kanematsu K; Takayanagi I
Arch Int Pharmacodyn Ther; 1996; 331(2):136-52. PubMed ID: 8937625
[TBL] [Abstract][Full Text] [Related]
12. Peripherally mediated antinociception of the mu-opioid receptor agonist 2-[(4,5alpha-epoxy-3-hydroxy-14beta-methoxy-17-methylmorphinan-6beta-yl)amino]acetic acid (HS-731) after subcutaneous and oral administration in rats with carrageenan-induced hindpaw inflammation.
Bileviciute-Ljungar I; Spetea M; Guo Y; Schütz J; Windisch P; Schmidhammer H
J Pharmacol Exp Ther; 2006 Apr; 317(1):220-7. PubMed ID: 16339394
[TBL] [Abstract][Full Text] [Related]
13. FE200041 (D-Phe-D-Phe-D-Nle-D-Arg-NH2): A peripheral efficacious kappa opioid agonist with unprecedented selectivity.
Vanderah TW; Schteingart CD; Trojnar J; Junien JL; Lai J; Riviere PJ
J Pharmacol Exp Ther; 2004 Jul; 310(1):326-33. PubMed ID: 14993260
[TBL] [Abstract][Full Text] [Related]
14. Pharmacological properties of R-84760, a novel kappa-opioid receptor agonist.
Fujibayashi K; Sakamoto K; Watanabe M; Iizuka Y
Eur J Pharmacol; 1994 Aug; 261(1-2):133-40. PubMed ID: 8001635
[TBL] [Abstract][Full Text] [Related]
15. Peripheral versus central antinociceptive actions of 6-amino acid-substituted derivatives of 14-O-methyloxymorphone in acute and inflammatory pain in the rat.
Fürst S; Riba P; Friedmann T; Tímar J; Al-Khrasani M; Obara I; Makuch W; Spetea M; Schütz J; Przewlocki R; Przewlocka B; Schmidhammer H
J Pharmacol Exp Ther; 2005 Feb; 312(2):609-18. PubMed ID: 15383636
[TBL] [Abstract][Full Text] [Related]
16. Role of histamine in rodent antinociception.
Malmberg-Aiello P; Lamberti C; Ghelardini C; Giotti A; Bartolini A
Br J Pharmacol; 1994 Apr; 111(4):1269-79. PubMed ID: 8032614
[TBL] [Abstract][Full Text] [Related]
17. Kappa-opioid receptor-mediated antinociception in the rat. II. Supraspinal in addition to spinal sites of action.
Millan MJ; Członkowski A; Lipkowski A; Herz A
J Pharmacol Exp Ther; 1989 Oct; 251(1):342-50. PubMed ID: 2571723
[TBL] [Abstract][Full Text] [Related]
18. Study of the involvement of K+ channels in the peripheral antinociception of the kappa-opioid receptor agonist bremazocine.
Amarante LH; Alves DP; Duarte ID
Eur J Pharmacol; 2004 Jun; 494(2-3):155-60. PubMed ID: 15212969
[TBL] [Abstract][Full Text] [Related]
19. Effect of the peripherally selective kappa-opioid agonist, asimadoline, on adjuvant arthritis.
Binder W; Walker JS
Br J Pharmacol; 1998 Jun; 124(4):647-54. PubMed ID: 9690855
[TBL] [Abstract][Full Text] [Related]
20. Involvement of nitric oxide in peripheral antinociception mediated by kappa- and delta-opioid receptors.
Nozaki-Taguchi N; Yamamoto T
Anesth Analg; 1998 Aug; 87(2):388-93. PubMed ID: 9706936
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]